New contraceptive methods
DOI:
https://doi.org/10.32385/rpmgf.v21i5.10171Keywords:
Low Dose Contraception, Alternative Routes of AdministrationAbstract
The new formulations of oral contraceptives have a better safety profile, maintaining the same benefits not apparent contraceptive recorded for the higher dosages. The new progestin, drospirenone presents an anti-mineralocorticoid with diuretic effect. The use of new routes of administration of hormones as the contraceptive transdermal, intra-vaginal, subcutaneous implantation or combined with the intrauterine device came facilitate adherence to method and reduce errors and omissions by failure of the test. But not abolished abandoning the method most frequently in the first year of use. The main reason is the irregularity of cycle with intermittent blood loss with amenorreias sometimes prolonged, with more frequent with progestin only contraception. The changes are attributed to inadequate endometrial proliferation, which, weakened, peels off partially. The treatment involves the temporary administration of estrogen.Downloads
Downloads
Published
Issue
Section
License
The authors will assign to the RPMGF the sole right to publish and distribute the content of the manuscript specified in this declaration via physical, electronic, broadcasting or any other medium that may come into existence. They also grant the RPMGF the right to use and exploit this manuscript, in particular by assigning, selling or licensing its content. This permission is permanent and takes effect from the moment the manuscript is submitted, has the maximum duration allowed by applicable Portuguese or international law and is of worldwide scope. The authors further declare that this assignment is made free of charge. If the RPMGF informs the authors that it is not going to publish their manuscript, the exclusive assignment of rights ceases forthwith.
The authors authorise the RPMGF (or any entity it may appoint) to act on their behalf when it believes that copyright may have been infringed.
